AUTOBAHN THERAPEUTICS
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders. Autobahn is leveraging a deep understanding of validated human biology coupled with its brain-targeting chemistry platform to develop thyroid hormone receptor beta agonist therapies that harness the regenerative power of the human body. The company’s pipeline is led by ABX-002 for the treatment of multiple sclerosis and adrenomyeloneuropathy (AMN), a rare genetic disorder. Autobahn Therapeutics is based in San Diego.
AUTOBAHN THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.autobahntx.com
Total Employee:
11+
Status:
Active
Contact:
+1 858 722-0037
Total Funding:
208.7 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF WordPress LetsEncrypt SSL By Default Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin Nginx
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Aspect Biosystems
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Neurogene
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sanofi
Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
VenoStent
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
Current Employees Featured
John Borkholder General Counsel & SVP, Administration @ Autobahn Therapeutics
General Counsel & SVP, Administration
2018-05-01
Kevin Finney Chairman and CEO @ Autobahn Therapeutics
Chairman and CEO
2019-11-01
Keith Lenden Co-Founder, President & COO @ Autobahn Therapeutics
Co-Founder, President & COO
2018-02-01
Gudarz Davar EVP, CMO @ Autobahn Therapeutics
EVP, CMO
2021-09-01
Founder
Investors List
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Series C - Autobahn Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Autobahn Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Autobahn Therapeutics
BVF Partners
BVF Partners investment in Series C - Autobahn Therapeutics
Monograph Capital
Monograph Capital investment in Series C - Autobahn Therapeutics
Insight Partners
Insight Partners investment in Series C - Autobahn Therapeutics
Newpath Management
Newpath Management investment in Series C - Autobahn Therapeutics
Canaan Partners
Canaan Partners investment in Series C - Autobahn Therapeutics
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series C - Autobahn Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - Autobahn Therapeutics
Official Site Inspections
http://www.autobahntx.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 169.75.82.34.bc.googleusercontent.com
- IP address: 34.82.75.169
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Autobahn Therapeutics"
About Us – Autobahn Therapeutics
Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of …See details»
Autobahn Therapeutics - Crunchbase Company Profile …
Contact Email info@autobahntx.com Phone Number +1 858 722-0037 Autobahn Therapeutics is a biotechnology company developing a portfolio of …See details»
Careers – Autobahn Therapeutics
For more information, visit www.autobahntx.com. We’re seeking high-performing individuals who are passionate about science and excited to work in a …See details»
Autobahn Therapeutics, Inc. | LinkedIn
Autobahntx.com 165 13 Comments Like Comment Share Autobahn Therapeutics, Inc. 6,670 followers 5mo Report this post As we observe World Mental Health Day, Autobahn is committed to raising awareness ...See details»
Autobahn Therapeutics, Inc. Overview | SignalHire Company Profile
Summary. Autobahn Therapeutics, Inc. is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas.See details»
Autobahn Therapeutics - Overview, News & Similar companies
Mar 13, 2024 Autobahn Therapeutics to Present at the Stifel 2024 Virtual CNS Days SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company leveraging its …See details»
Autobahn Therapeutics, Inc. | MedPath
First Posted Date 2024-10-09 Last Posted Date 2024-12-17 Lead Sponsor Autobahn Therapeutics, Inc. Target Recruit Count 230 Registration Number NCT06633016See details»
Autobahn Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Autobahn Therapeutics, Inc. Company Overview, Contact Details ...
Jul 24, 2024 Autobahn Therapeutics, Inc. partnered with Allocated Bullion Exchange Ltd on Sep 11th '23. SAN DIEGO, September 11, 2023 --( BUSINESS WIRE )--Autobahn Therapeutics, a …See details»
Autobahn Therapeutics - workinbiotech.com
Autobahn Therapeutics is developing regenerative medicines to treat central nervous system (CNS) disorders. Due to the high failure rate in CNS drug development Autobahn is taking a …See details»
Heather Smith – Autobahn Therapeutics
Ms. Smith holds a B.A. in psychology from University of California, San Diego and an MBA with emphasis in organization management from Webster University. About Us. Our Mission; …See details»
Autobahn Therapeutics, Inc. (Autobahn Therapeutics, Inc.) - 药物管 …
For more information, visit www.autobahntx.com . About ABX-002 ABX-002 is an orally administered, potent and selective thyroid hormone beta receptor (TRβ) agonist designed to …See details»
Senior Manager Clinical Operations - LinkedIn
Nov 9, 2024 Autobahn Therapeutics is seeking a Manager/Senior Manager, Clinical Operations to join its team to oversee clinical pharmacology (BE, DDI, Mass Balance and SAD/MAD) studies.See details»
Autobahn Therapeutics Announces Orphan Drug Designation
Aug 4, 2021 The company’s pipeline is led by ABX-002, a thyroid hormone receptor beta agonist prodrug for the treatment of adrenomyeloneuropathy (AMN), a rare genetic disorder. Autobahn …See details»
Autobahn Therapeutics Inc Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. ... The official website of Autobahn Therapeutics Inc: autobahntx.com. 3. What is the revenue of Autobahn …See details»
Autobahn Therapeutics Completes Oversubscribed $100 Million …
SAN DIEGO, July 24, 2024--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic …See details»
Betsy Vaughn – Autobahn Therapeutics
Ms. Vaughn is a seasoned human resources executive with over 20 years in the biotech and financial services industries. Prior to Autobahn she served at Illumina during an 8-year period …See details»
autobahntx.com Reviews: Is this site a scam or legit?
Organization Domains By Proxy, LLC . Street DomainsByProxy.com 100 S. Mill Ave, Suite 1600 . State Arizona ... autobahntx.com is a suspicious website, given all the risk factors and data …See details»
News – Autobahn Therapeutics
Autobahn Therapeutics Advances ABX-002, its Lead Oral Treatment for Major Depressive Disorder, into Multi-Ascending Dose Portion of Phase 1 TrialSee details»
Office of the Texas Governor | Greg Abbott
2 days ago Office of the Texas Governor. P.O. Box 12428 Austin Texas 78711 (512) 463-2000See details»